chrisvoncsefalvay/vaers-outcomes huggingface dataset:
a red arm and a bit of a headache; a red arm and a bit of a headache; previously 2 doses of MODERNA COVID-19 VACCINE; previously 2 doses of MODERNA COVID-19 VACCINE; previously 2 doses of MODERNA COVID-19 VACCINE; This is spontaneous report from a contactable consumer (patient).   An 84-year-old female received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single (Pfizer Covid19 booster dose) for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received previously 2 doses of MODERNA COVID-19 VACCINE (MODERNA COVID-19 VACCINE, Lot Number: not reported) via an unspecified route of administration on an unspecified date (early) in Jan2021 where she experienced a bit of headache, a rash like mosquito bite but not itchy and her arm was sore. The patient went and got her booster shot from Pfizer a few days ago, and she had a red arm and a bit of a headache. The patient received previously 2 doses of MODERNA COVID-19 VACCINE. The patient said that there was no side effects at all compared to withheld, the 2nd shot of withheld hurted a lot for one night but everything was fine. She wanted to know when she could get another booster shot of Pfizer. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Patient developed swelling of his LE entire thigh few hours after his DTaP & IPV.
72 hrs post immunization onset of reactive arthritis in all joints, especially those in both arms - shoulders, elbows, wrists, fingers. Right hand numbness. Lesser joint pain in lower joints - ankles and hips primarily.   Pain was intense enough to seek treatment at ER. Prednisone prescribed. Outcome pending.
Arm is very sore; redness around injection site i Injection site is veey red and has gotten worse; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm is very sore) and VACCINATION SITE ERYTHEMA (redness around injection site i Injection site is veey red and has gotten worse) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is very sore) and VACCINATION SITE ERYTHEMA (redness around injection site i Injection site is veey red and has gotten worse). At the time of the report, PAIN IN EXTREMITY (Arm is very sore) and VACCINATION SITE ERYTHEMA (redness around injection site i Injection site is veey red and has gotten worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
each of them feeling sick; aching all over for a day or two; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "each of them feeling sick"; PAIN (non-serious), outcome "recovered", described as "aching all over for a day or two".  Additional information: Caller reports receiving 6 Pfizer COVID-19 vaccine injections in the past (dates and formulations not provided) and after each of them felt sick and aching all over for a day or two.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300312955 Same patient/vaccine/event, different dose;
Swollen and slightly uncomfortable sub-mandibular glands for about 2 weeks. Did not initially pay attention so exact dates of onset and resolution unknown. Just thought it might be related. Thus the report. No known sinus or dental problems that would cause same.
patient started developing rash two days after vaccination. Went to doctor and was diagnosed with shingles 8-12-19.  Rash developed on left  side along bra strap line.
This 77  year old male received the Covid shot on  2/22/21    and went to the ED and admitted on 4/28/21 with the  diagnoses listed below and died on 5/5/21. cause of death unknown at time of report
numbness in head 1 hour after vax, couldnt swallow, numbness throughout whole body, high anxiety
Constant pain on both shoulder. Difficulty to sleep. And unable to get out of bed. Still in pain even with pain medication. Under treatment at pain clinic.
according to the autopsy report it contributed to killing my mother; Initial information was received on 04-Dec-2020 regarding an unsolicited valid serious social media case from a consumer via social media.  This case involves female patient (unknown age) whom it was reported that according to the autopsy report INFLUENZA VACCINE contributed to killing her (death).  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) not reported via an unknown route at an unknown administration site prophylactic vaccination.  On an unknown date, the patient died due to INFLUENZA VACCINE (death) (unknown latency). Additionally, this event was assessed as medically significant.  It was not reported if the patient received any corrective treatment before death.  An autopsy was done, however details were not reported.  Information on the batch number was requested.; Sender's Comments: This is a poorly documented social media case received from social media involves a female patient (unknown age) who died after receiving INFLUENZA VACCINE (unknown manufacturer). Time to onset is unknown. It was reported that according to the autopsy report it contributed to killing her. However there is no additional information regarding patient's relevant medical history, health condition at time of vaccination and laboratory tests ruling out other alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.; Reported Cause(s) of Death: according to the autopsy report it contributed to killing my mother
Bell?s palsy in left side of face experienced within 24 hours of shot plus large, ?sack-like? inflammation under the armpit on same side (lymph nodes but atypical) .      Family Doctor visit confirmed and out on course of prednisone plus ordered bloodwork.
diarrhea; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received his 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL9261) at single dose on 22Jan2021 about 14:40 intramuscular in right shoulder for COVID-19 vaccination. Medical history, concomitant drugs, and family medical history relevant to event were reported as "none". Patient had no history of all previous immunization with the Pfizer vaccine considered as suspect, no additional Vaccines Administered on Same Date of the Pfizer Suspect, no prior vaccinations (within 4 weeks), no relevant tests. Patient experienced diarrhea at about 8-9am 25Jan2021. Patient reported that he had had diarrhea for the last 24 hours (as of 26Jan2021). It started on 25Jan2021.  Patient stated that his diarrhea did not go away. Usually he would go to the bathroom 3-4 times and it would go away, but this was not going away. No investigation assessment performed. The event did not require a visit to Emergency Room/ Physician Office. Outcome of the event was not resolved.
Injection site in Right upper arm - tender to touch, swelling, muscular pain that radiated to shoulder/Axilla area and down to elbow at times. No home Tx done. Instructed to take NSAIDS and ice arm.
Information has been received from a pharmacy intern concerning her co-worker's grandson, a 4 year old male with no pertinent medication history who on 01-DEC-2005 was vaccinated with the first dose of VARIVAX (Merck) (Lot # was not provided). Concomitant therapy included MMR II and POLIO (unspecified). No lab diagnostics studies performed. In March 2006, the patient developed pneumonia and was admitted into hospital. The patient was in the hospital for three days and released. However, one week later, the patient developed shingles. After the recovery, the patient later received the second dose of VARIVAX (Merck). Follow-up information has been received from the physician concerning the patient who last visited the physician' office on 20-FEB-2006. Additional information has been requested.
Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received vaccine past its 30-days Exp date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2022 at 12:24 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Mar-2022 at 12:24 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient received Moderna vaccine past its 30 day of expiry date. Vaccine went into 2-to-8-degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
C/o hives that started 36 hours after receiving GARDASIL.  Pt also changed eye medication on that day from TOBRADEX ointment to TOBRADEX drops.  Has h/o hives frequently gets them with viruses, "these are worse".  Not ill.  Tried BENADRYL & CLARITIN which did not help.  Seen in office on 7/29/08 - for urticaria possible allergic rxn to GARDASIL or TOBRADEX drops.  Rx given for hydroxyzine 25mg one Q6 hours prn, may also try ZYRTEC, prn QD.
Developed a rash that would start in one area of my body extremely itchy almost unbearable. That spot would clear up then would move to another part of my body and the other one would clear up. Primarily was located on my inner thigh, upper arms, top of foot and legs,  This lasted for 3 days. I now periodically have a random small rash of about 3 or 4 bumps that breaks out out of nowhere and lasts a few hours.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 11:50 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 11:50 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 56.34.  No concomitant medications were reported.  Batch number 030B21A administered on 03-Apr-2021 with temperature 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 03-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 24-JUN-2013 the patient was vaccinated with PNEUMOVAX23 (lot# 672057/1417AA, expiration date 22-JUN-2013) (strength and total daily dose not reported). It was reported that the patient received an expired dose of PNEUMOVAX23. No adverse effect was reported. It was unspecified whether the patient sought for medical attention. The outcome was unknown. Additional information has been requested.
Patient is fully vaccinated.  COVID + on 1/17/2022 at admission to hospital. 66y.o. male who came with syncopal episode. Patient stated that patient was taking shower when he felt lightheaded and sat down in shower chair. Patient is also complaining for cough, tiredness and weakness started a few days ago. Pt CT chest showed, No CT evidence for central or segmental Pulmonary Embolism.  Multiple foci focal bilateral groundglass opacities likely reflective of infectious/inflammatory process including atypical pneumonia such as Covid 19. Cr 1.89. Hg 7.2. D dimer 4,471. Normal troponin. CT head: No acute intracranial findings are identified.Patient did complete a short course of remdesivir but did not require further inpatient treatment due to him not being hypoxic.On admission and occult stool was positive however patient denies any acute GI bleed. Patient was discharged to home.  Stable.
patient is having an itching feeling across their face and upper body that has onset a few days after their vaccination. This happens mostly at night every other day and is relieved with Benadryl.
Arm pain, general muscle pain, body aches, headache, fatigue, nausea, and lethargy.
4 year vaccines administered 9/13/10. Received call from mom 9/15/10 stating (R) upper arm swollen, red, warm to touch. Child running temp 101, vomiting. Pediatrician saw patient. Advised to avoid tetanus vaccines. Tx with BACTRIM.
This form is confusing.  I am reporting that I contracted COVID with symptom onset on Friday 7/15/22 and  a positive test on Saturday July 16, 2022
rash on the arm where the vaccine was administered into; she said, "it looks blistery".; rash on the arm where the vaccine was administered into; she said, "it looks blistery".; This is a spontaneous report from a non-contactable other health professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), batch/lot number and expiry date not provided, via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced rash on the arm where the vaccine was administered into; she said, "it looks blistery". The outcome of events was unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Dizziness, lightheaded, faint, nearly blacked out, hyperventilating, tingling in extremities, slurred speech, headache, chills, fever, elevated heart rate, loss of motor skills, weakness, soreness at injection site  Bloodwork, CT scan, EKG performed Received IV line of fluids and rest Still weak and bad headache after leaving hospital; went home and had ibuprofen to help with headache and continued to rest; feeling much better next day
Patient received immunizations yesterday-mom called today with complaints of redness/bump at site, itching at site.
Information has been received from a nurse, concerning a male who on approximately 28-JUL-2008 was vaccinated with ZOSTAVAX (Oka/Merck), 0.65 mL, SC. It was reported that on the same day the patient had a bump form at the ZOSTAVAX (Oka/Merck) injection site that was warm and hurt. At the time of the report, the patient had not recovered. The patient sought medical attention, saw the nurse. No additional AE information reported. Additional information has been requested.
Got the shingles vaccine and only got a mild case/ Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included kidney infection.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shingles vaccine and only got a mild case/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 25-MAR-2023 This case was reported by patient via interactive digital media. The patient reported that he or she received shingles vaccine and experienced shingles. The reporter stated that it was worse than worse kidney infection that he or she ever had. The physician stated that the his or her case was mild because he or she received shingles vaccine. The reporter reported that the shingles was felt like his or her kidney went septic and had to be removed. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory details were unknown at a time of reporting. The follow-up could not be possible as the as no contact details were available.
Hives at injection site on/off 3-4 days followed by (L) shoulder tenderness & stiffness.
This case was reported by a physician, via a GSK representative, that described the occurrence of high fever in a 4-month-old subject of unspecified gender who was vaccinated with PEDIARIX. Concurrent vaccinations given on the same date as PEDIARIX included ACTHIB, ROTATEQ, oral and  unspecified PREVNAR unknown. On an unspecified date, the subject received the second dose of PEDIARIX. At an unspecified time after vaccination with PEDIARIX, the subject experienced a high fever, reported to be in the 103 degree Fahrenheit range. At an unspecified time after vaccination with PEDIARIX, BLOOD was drawn from the subject and the test results showed a white blood count "shift to the left", but no bacteria was detected. The subject was treated with at least one dose of  Rocephin. The fever was reported to be resolved within 24 hours, but the outcome of the abnormal white blood cell count was not reported.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 3:38 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 3:38 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  On 03-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 210, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 30-Mar-2021, vial was moved to clinic on 03-Apr-2021. 20 vials were sent to clinic. Vaccine BUD date was 29-Apr-2021.  On 03-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: 38, 9 AM: 34, 10 AM: 38, 11 AM: 42, 12 AM: 41, 1PM: 41, 2 PM: 41, 3 PM: 40, 4 PM: 40 and 5 PM: 41.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient was seated waiting after her vaccination. She collapses to the floor. I went out after being alerted what happened and flipped her from her face, she was awake and confused as to what had happened. I sat with her while our front store manager grabbed her water. I asked if she felt she needed an ambulance and seeing as she was breathing fine and starting to come to she said she did not want an ambulance. She later informed our front store manager that she had fainted 3 times that morning.